Desmoglein autoimmunity in the pathogenesis of pemphigus

References

• Futei Y, Amagai M, Ishii K, et al. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. J Dermatol Sci 2001; 26: 55–61
   PubMed Web of Science ®Google Scholar
• Anhalt GJ, Labib RS, Voorhees JJ, et al. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982; 306: 1189–1196
   PubMed Web of Science ®Google Scholar
• Schiltz JR, Michel B. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol 1976; 67: 254–260
   PubMed Web of Science ®Google Scholar
• Swanson DL, Dahl MV. Methylprednisolone inhibits pemphigus acantholysis in skin cultures. J Invest Dermatol 1983; 81: 258–260
   PubMed Web of Science ®Google Scholar
• Stanley JR, Koulu L, Thivolet C. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest 1984; 74: 313–320
   PubMed Web of Science ®Google Scholar
• Koulu L, Kusumi A, Steinberg MS, et al. Human autoantibodies against a desmosomal core protein in pemphigus foliaceus. J Exp Med 1984; 160: 1509–1518
   PubMed Web of Science ®Google Scholar
• Stanley JR, Koulu L, Klaus-Kovtun V, et al. A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol 1986; 136: 1227–1230
   PubMed Web of Science ®Google Scholar
• Wilgram GF, Caufield JB, Madgic EB. An electron microscopic study of acantholysis and dyskeratosis in pemphigus foliaceous: With a special note on peculiar intracytoplasmic bodies. J Invest Dermatol 1964; 43: 287–299
   PubMedGoogle Scholar
• Nguyen VT, Ndoye A, Shultz LD, et al. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest 2000; 106: 1467–1479
   PubMed Web of Science ®Google Scholar
• Ding X, Diaz LA, Fairley JA, et al. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. J Invest Dermatol 1999; 112: 739–743
   PubMed Web of Science ®Google Scholar
• Amagai M, Hashimoto T, Green KJ, et al. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 1995; 104: 895–901
   PubMed Web of Science ®Google Scholar
• Warren SJ, Lin MS, Giudice GJ, et al. The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research. N Engl J Med 2000; 343: 23–30
   PubMed Web of Science ®Google Scholar
• Wu H, Wang ZH, Yan A, et al. Protection against pemphigus foliaceus by desmoglein 3 in neonates. N Engl J Med 2000; 343: 31–35
   PubMedGoogle Scholar
• Whittock NV, Bower C. Targetting of desmoglein 1 in inherited and acquired skin diseases. Clin Exp Dermatol 2003; 28: 410–415
   PubMedGoogle Scholar
• Sekiguchi M, Futei Y, Fujii Y, et al. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol 2001; 167: 5439–5448
   PubMed Web of Science ®Google Scholar
• McGrath JA. Inherited disorders of desmosomes. Australas J Dermatol 2005; 46: 221–229
   PubMedGoogle Scholar
• Descargues P, Deraison C, Bonnart C, et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 2005; 37: 56–65
   PubMed Web of Science ®Google Scholar
• Hanakawa Y, Stanley JR. Mechanisms of blister formation by staphylococcal toxins. J Biochem (Tokyo) 2004; 136: 747–750
   PubMedGoogle Scholar
• Payne AS, Hanakawa Y, Amagai M, et al. Desmosomes and disease: Pemphigus and bullous impetigo. Curr Opin Cell Biol 2004; 16: 536–543
   PubMed Web of Science ®Google Scholar
• Amagai M. Desmoglein as a target in autoimmunity and infection. J Am Acad Dermatol 2003; 48: 244–252
   PubMedGoogle Scholar
• Gniadecki R, Jemec GB, Thomsen BM, et al. Relationship between keratinocyte adhesion and death: Anoikis in acantholytic diseases. Arch Dermatol Res 1998; 290: 528–532
   PubMed Web of Science ®Google Scholar
• Janes SM, Watt FM. New roles for integrins in squamous-cell carcinoma. Nat Rev Cancer 2006; 6: 175–183
   PubMed Web of Science ®Google Scholar
• Waschke J, Bruggeman P, Baumgartner W, et al. Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction. J Clin Invest 2005; 115: 3157–3165
   PubMed Web of Science ®Google Scholar
• Koulu L, Stanley JR. Clinical, histologic, and immunopathologic comparison of pemphigus vulgaris and pemphigus foliaceus. Semin Dermatol 1988; 7: 82–90
   PubMedGoogle Scholar
• Stanley JR, Yaar M, Hawley-Nelson P, et al. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest 1982; 70: 281–288
   PubMed Web of Science ®Google Scholar
• Eyre RW, Stanley JR. Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest 1988; 81: 807–812
   PubMed Web of Science ®Google Scholar
• Korman NJ, Eyre RW, Klaus-Kovtun V, et al. Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. N Engl J Med 1989; 321: 631–635
   PubMed Web of Science ®Google Scholar
• Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991; 67: 869–877
   PubMed Web of Science ®Google Scholar
• Amagai M, Karpati S, Prussick R, et al. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 1992; 90: 919–926
   PubMed Web of Science ®Google Scholar
• Karpati S, Amagai M, Prussick R, et al. Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes. J Cell Biol 1993; 122: 409–415
   PubMed Web of Science ®Google Scholar
• Amagai M, Hashimoto T, Shimizu N, et al. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 1994; 94: 59–67
   PubMed Web of Science ®Google Scholar
• Memar OM, Rajaraman S, Thotakura R, et al. Recombinant desmoglein 3 has the necessary epitopes to adsorb and induce blister-causing antibodies. J Invest Dermatol 1996; 106: 261–268
   PubMedGoogle Scholar
• Amagai M, Tsunoda K, Suzuki H, et al. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J Clin Invest 2000; 105: 625–631
   PubMed Web of Science ®Google Scholar
• Ohyama M, Amagai M, Tsunoda K, et al. Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris. J Invest Dermatol 2002; 118: 199–204
   PubMed Web of Science ®Google Scholar
• Tsunoda K, Ota T, Aoki M, et al. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 2003; 170: 2170–2178
   PubMed Web of Science ®Google Scholar
• Bhol KC, Ahmed AR. Production of non-pathogenic human monoclonal antibodies to desmoglein 3 from pemphigus vulgaris patient. Autoimmunity 2002; 35: 87–91
   PubMed Web of Science ®Google Scholar
• Yeh SW, Cavacini LA, Bhol KC, et al. Pathogenic human monoclonal antibody against desmoglein 3. Clin Immunol 2006; 120: 68–75
   PubMed Web of Science ®Google Scholar
• Payne AS, Ishii K, Kacir S, et al. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 2005; 115: 888–899
   PubMed Web of Science ®Google Scholar
• Koch PJ, Mahoney MG, Ishikawa H, et al. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 1997; 137: 1091–1102
   PubMed Web of Science ®Google Scholar
• Allen E, Yu QC, Fuchs E. Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J Cell Biol 1996; 133: 1367–1382
   PubMed Web of Science ®Google Scholar
• Nishifuji K, Amagai M, Kuwana M, et al. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: Requirement of T cell collaboration for autoantibody production. J Invest Dermatol 2000; 114: 88–94
   PubMed Web of Science ®Google Scholar
• Veldman C, Pahl A, Beissert S, et al. Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells. J Immunol 2006; 176: 3215–3222
   PubMed Web of Science ®Google Scholar
• Nguyen VT, Ndoye A, Grando SA. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity. Am J Pathol 2000; 157: 1377–1391
   PubMed Web of Science ®Google Scholar
• Bystryn JC, Grando SA. A novel explanation for acantholysis in pemphigus vulgaris: The basal cell shrinkage hypothesis. J Am Acad Dermatol 2006; 54: 513–516
   PubMed Web of Science ®Google Scholar
• Wolff K, Schreiner E. Ultrastructural localization of pemphigus autoantibodies within the epidermis. Nature 1971; 229: 59–61
   PubMed Web of Science ®Google Scholar
• Jones JC, Yokoo KM, Goldman RD. A cell surface desmosome-associated component: Identification of tissue-specific cell adhesion molecule. Proc Natl Acad Sci USA 1986; 83: 7282–7286
   PubMedGoogle Scholar
• Yoshida K, Takae Y, Saito H, et al. Cutaneous type pemphigus vulgaris: A rare clinical phenotype of pemphigus. J Am Acad Dermatol 2005; 52: 839–845
   PubMed Web of Science ®Google Scholar
• Ishii K, Amagai M, Ohata Y, et al. Development of pemphigus vulgaris in a patient with pemphigus foliaceus: Antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay. J Am Acad Dermatol 2000; 42: 859–861
   PubMed Web of Science ®Google Scholar
• Amagai M, Tsunoda K, Zillikens D, et al. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999; 40: 167–170
   PubMed Web of Science ®Google Scholar
• Mahoney MG, Wang Z, Rothenberger K, et al. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999; 103: 461–468
   PubMed Web of Science ®Google Scholar
• Amagai M, Koch PJ, Nishikawa T, et al. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol 1996; 106: 351–355
   PubMed Web of Science ®Google Scholar
• Jamora MJ, Jiao D, Bystryn JC. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol 2003; 48: 976–977
   PubMedGoogle Scholar
• Hilario-Vargas J, Dasher DA, Li N, et al. Prevalence of anti-desmoglein-3 antibodies in endemic regions of Fogo Selvagem in Brazil. J Invest Dermatol 2006; 126: 2044–2048
   PubMed Web of Science ®Google Scholar
• Kurzen H, Moll I, Moll R, et al. Compositionally different desmosomes in the various compartments of the human hair follicle. Differentiation 1998; 63: 295–304
   PubMedGoogle Scholar
• Kljuic A, Bazzi H, Sundberg JP, et al. Desmoglein 4 in hair follicle differentiation and epidermal adhesion: Evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell 2003; 113: 249–260
   PubMed Web of Science ®Google Scholar
• Nagasaka T, Nishifuji K, Ota T, et al. Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome. J Clin Invest 2004; 114: 1484–1492
   PubMed Web of Science ®Google Scholar
• Jones JC, Yokoo KM, Goldman RD. Further analysis of pemphigus autoantibodies and their use in studies on the heterogeneity, structure, and function of desmosomes. J Cell Biol 1986; 102: 1109–1117
   PubMed Web of Science ®Google Scholar
• Kowalczyk AP, Borgwardt JE, Green KJ. Analysis of desmosomal cadherin-adhesive function and stoichiometry of desmosomal cadherin–plakoglobin complexes. J Invest Dermatol 1996; 107: 293–300
   PubMed Web of Science ®Google Scholar
• Koeser J, Troyanovsky SM, Grund C, et al. De novo formation of desmosomes in cultured cells upon transfection of genes encoding specific desmosomal components. Exp Cell Res 2003; 285: 114–130
   PubMed Web of Science ®Google Scholar
• Sato M, Aoyama Y, Kitajima Y. Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. Lab Invest 2000; 80: 1583–1592
   PubMed Web of Science ®Google Scholar
• Calkins CC, Setzer SV, Jennings JM, et al. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem 2006; 281: 7623–7634
   PubMed Web of Science ®Google Scholar
• Cirillo N, Femiano F, Gombos F, et al. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes. FEBS Lett 2006; 580: 3276–3281
   PubMed Web of Science ®Google Scholar
• Shimizu A, Ishiko A, Ota T, et al. IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model. J Invest Dermatol 2004; 122: 1145–1153
   PubMed Web of Science ®Google Scholar
• Caldelari R, de BA, Baumann D, et al. A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol 2001; 153: 823–834
   PubMed Web of Science ®Google Scholar
• Vasioukhin V, Bowers E, Bauer C, et al. Desmoplakin is essential in epidermal sheet formation. Nat Cell Biol 2001; 3: 1076–1085
   PubMed Web of Science ®Google Scholar